Search Results - "Conder, Mary Lee"

Refine Results
  1. 1

    Estimation of hERG inhibition of drug candidates using multivariate property and pharmacophore SAR by Johnson, Stephen R., Yue, Hongwen, Conder, Mary Lee, Shi, Hong, Doweyko, Arthur M., Lloyd, John, Levesque, Paul

    Published in Bioorganic & medicinal chemistry (15-09-2007)
    “…We describe the development and validation of an in silico model of hERG inhibition. The model includes several factors not previously reported for the…”
    Get full text
    Journal Article
  2. 2

    Pyrrolidine amides of pyrazolodihydropyrimidines as potent and selective Kv1.5 blockers by LLOYD, John, FINLAY, Heather J, HONG SHI, HUANG, Christine, DANSHI LI, HUABIN SUN, LEVESQUE, Paul, VACARRO, Wayne, HYUNH, Tram, KOVER, Alexander, BHANDARU, Rao, LIN YAN, ATWAL, Karnail, LEE CONDER, Mary, JENKINS-WEST, Tonya

    Published in Bioorganic & medicinal chemistry letters (15-02-2010)
    “…Design and synthesis of pyrazolodihydropyrimidines as KV1.5 blockers led to the discovery of 7d as a potent and selective antagonist. This compound showed…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Functional Expression of Two KvLQT1-related Potassium Channels Responsible for an Inherited Idiopathic Epilepsy by Yang, Wen-Pin, Levesque, Paul C., Little, Wayne A., Conder, Mary Lee, Ramakrishnan, Pankajavalli, Neubauer, Michael G., Blanar, Michael A.

    Published in The Journal of biological chemistry (31-07-1998)
    “…Benign familial neonatal convulsions (BFNC), a class of idiopathic generalized epilepsy, is an autosomal dominantly inherited disorder of newborns. BFNC has…”
    Get full text
    Journal Article
  5. 5

    KvLQT1, a Voltage-Gated Potassium Channel Responsible for Human Cardiac Arrhythmias by Yang, Wen-Pin, Levesque, Paul C., Little, Wayne A., Conder, Mary Lee, Shalaby, Fouad Y., Blanar, Michael A.

    “…The clinical features of long QT syndrome result from episodic life-threatening cardiac arrhythmias, specifically the polymorphic ventricular tachycardia…”
    Get full text
    Journal Article
  6. 6
  7. 7
  8. 8

    Pseudosaccharin amines as potent and selective KV1.5 blockers by Lloyd, John, Finlay, Heather J., Kover, Alexander, Johnson, James, Pi, Zulan, Jiang, Ji, Neels, James, Cavallaro, Cullen, Wexler, Ruth, Conder, Mary Lee, Shi, Hong, Li, Danshi, Sun, Huabin, Chimalakonda, Anjaneya, Huang, Christine, Salvati, Mark, Levesque, Paul

    Published in Bioorganic & medicinal chemistry letters (01-11-2015)
    “…Synthesis of pseudosaccharin amines as KV1.5 blockers led to the discovery of potent antagonists such as 17d. These compounds had potent pharmacodynamic…”
    Get full text
    Journal Article
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14

    Triazolo and imidazo dihydropyrazolopyrimidine potassium channel antagonists by Finlay, Heather J., Jiang, Ji, Caringal, Yolanda, Kover, Alexander, Conder, Mary Lee, Xing, Dezhi, Levesque, Paul, Harper, Timothy, Hsueh, Mei Mann, Atwal, Karnail, Blanar, Michael, Wexler, Ruth, Lloyd, John

    Published in Bioorganic & medicinal chemistry letters (15-03-2013)
    “…Previously disclosed C6 amido and benzimidazole dihydropyrazolopyrimidines were potent and selective blockers of IKur current. Syntheses and SAR for C6…”
    Get full text
    Journal Article
  15. 15

    Dihydropyrazolopyrimidine inhibitors of K(V)1.5 (I(Kur)) by Vaccaro, Wayne, Huynh, Tram, Lloyd, John, Atwal, Karnail, Finlay, Heather J, Levesque, Paul, Conder, Mary Lee, Jenkins-West, Tonya, Shi, Hong, Sun, Lucy

    Published in Bioorganic & medicinal chemistry letters (15-12-2008)
    “…A series of dihydropyrazolopyrimidine inhibitors of K(V)1.5 (I(Kur)) have been identified. The synthesis, structure-activity relationships and selectivity…”
    Get full text
    Journal Article
  16. 16
  17. 17

    Pyrano-[2,3 b]-pyridines as potassium channel antagonists by Finlay, Heather J., Lloyd, John, Nyman, Michael, Conder, Mary Lee, West, Tonya, Levesque, Paul, Atwal, Karnail

    Published in Bioorganic & medicinal chemistry (15-04-2008)
    “…The design and synthesis of a series of highly functionalized pyrano-[2,3 b]-pyridines is described. These compounds were assayed for their ability to block…”
    Get full text
    Journal Article
  18. 18

    Benzopyran sulfonamides as Kv1.5 potassium channel blockers by LLOYD, John, ATWAL, Karnail S, JENKINS-WEST, Tonya, LEVESQUE, Paul, FINLAY, Heather J, NYMAN, Michael, HUYNH, Tram, BHANDARU, Rao, KOVER, Alexander, SCHMIDT, Joan, VACCARO, Wayne, CONDER, Mary Lee

    Published in Bioorganic & medicinal chemistry letters (15-06-2007)
    “…K(V)1.5 blockers have the potential to be atrium-selective agents for treatment of atrial fibrillation. The benzopyrans provide a template for the synthesis of…”
    Get full text
    Journal Article
  19. 19

    Pyrrolidine amides of pyrazolodihydropyrimidines as potent and selective K V1.5 blockers by Lloyd, John, Finlay, Heather J., Vacarro, Wayne, Hyunh, Tram, Kover, Alexander, Bhandaru, Rao, Yan, Lin, Atwal, Karnail, Conder, Mary Lee, Jenkins-West, Tonya, Shi, Hong, Huang, Christine, Li, Danshi, Sun, Huabin, Levesque, Paul

    “…Design and synthesis of pyrazolodihydropyrimidines as K V1.5 blockers led to the discovery of 7d as a potent and selective antagonist. This compound showed…”
    Get full text
    Journal Article
  20. 20

    Dihydropyrazolopyrimidine Inhibitors of K sub(V)1.5 (I sub(Kur)) by Vaccaro, Wayne, Huynh, Tram, Lloyd, John, Atwal, Karnail, Finlay, Heather J, Levesque, Paul, Conder, Mary Lee, Jenkins-West, Tonya, Shi, Hong, Sun, Lucy

    Published in Bioorganic & medicinal chemistry (01-12-2008)
    “…A series of dihydropyrazolopyrimidine inhibitors of K sub(V)1.5 (I sub(Kur)) have been identified. The synthesis, structure-activity relationships and…”
    Get full text
    Journal Article